Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer
National Cancer Institute, Egypt
National Cancer Institute, Egypt
Institut Claudius Regaud
Yale University
Hoffmann-La Roche
Daiichi Sankyo
Debiopharm International SA
The Lymphoma Academic Research Organisation
Medical University of Vienna
Memorial Sloan Kettering Cancer Center
Stanford University
Shanghai Pulmonary Hospital, Shanghai, China
City of Hope Medical Center
City of Hope Medical Center
Astellas Pharma Inc
Shanghai Pulmonary Hospital, Shanghai, China
Eisai Inc.
Therapeutic Advances in Childhood Leukemia Consortium
Henry Ford Health System
University of California, San Francisco
Therapeutic Advances in Childhood Leukemia Consortium
The Lymphoma Academic Research Organisation
Roswell Park Cancer Institute
Chipscreen Biosciences, Ltd.
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Celgene
University of Maryland, Baltimore
The University of Hong Kong
University Hospital, Bonn
Asan Medical Center
University of Pittsburgh
Sun Yat-sen University
Guangxi Medical University
OHSU Knight Cancer Institute
Seattle Children's Hospital
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
Case Comprehensive Cancer Center
University Hospital, Lille
City of Hope Medical Center
Children's Oncology Group
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
La Jolla Pharmaceutical Company
Columbia University
Roswell Park Cancer Institute
ChineseAMS
Northwestern University